DELAND, Fla. — As of Monday, April 20, AI metal detectors will be rolled out at DeLand High School — the last of Volusia County’s 10 high schools to implement the new technology on school grounds.

Fantastic multi-frequency performance for an affordable price. It has four search modes and works better in wet conditions than cheaper alternatives. The main drawback is that the headphones are ...

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before. Analysts have questioned whether Novo can remain a leader in the highly competitive market ...

See more of our coverage in your search results. Add The New York Post on Google The Justice Department on Thursday released the clearest footage yet of White House Correspondents’ Dinner shooting ...

KENOSHA — In April, both the Kenosha Unified School District and Milwaukee Public Schools finished rolling out metal detectors across parts of their districts. The Kenosha Unified School District ...

As they arrived, dinner attendees were able to enter the Hilton Hotel after presenting a paper invitation to event staff. Inside, individual receptions hosted by different news organizations had their ...

Major sell-offs tend to follow the same blueprint, and Novo's 72% plunge is no exception. A few years ago Novo stock surged, supported by explosive demand for injectable GLP-1 therapies that ...

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce. Novo Nordisk’s U.S.-listed shares ...

Don't go out wandering aimlessly looking for treasure. A little research can make your metal detecting hobby much more rewarding. By Eric Alt Published Apr 11, 2026 1:28 PM EDT Add Popular Science ...

Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its production facility in Bloomington, Indiana, which chips in on the blockbuster GLP-1 medications Ozempic and Wegovy. All told, ...

Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for the Danish drugmaker to diversify after it lost ground to rivals in the competitive ...

Novo Nordisk A/S’s Chairman Lars Rebien Sorensen faced intense scrutiny from investors at the company’s annual general meeting on Thursday, the first after his boardroom coup last year. Sorensen and ...